A prospective, randomized and double blind once-monthly oral Ibandronate and Risedronate in post-menopausal osteoporosis leprosy patients. Int J of Biomed & Adv Res [Internet]. 2017 Nov. 30 [cited 2026 Mar. 14];8(11):407-15. Available from: https://ssjournals.co.in/index.php/ijbar/article/view/4474